Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Cerilliant
QuintilesIMS
UBS
Healthtrust
Citi
Medtronic
Farmers Insurance
McKesson
Johnson and Johnson

Generated: January 23, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,188,835

« Back to Dashboard

Summary for Patent: 5,188,835
Title: Intravaginal devices
Abstract:The invention concerns an intravaginal device comprising a combination of 17.beta.-estradiol and a supporting matrix for treating hypoestrogenic women. The device releases continously 17.beta.-estradiol at a rate of about 0.5 to about 25 .mu.g/24 h. The invention also comprises a method of preparing the device and a method of treating hypoestrogenic women by using the device.
Inventor(s): Lindskog; Inga M. (Helsingborg, SE), Sjogren; Bengt C. H. (Viken, SE), Andersson; Sven-Borje (Od.ANG.kra, SE)
Assignee: Kabi Pharmacia AB (Uppsala, SE)
Application Number:07/793,484
Patent Claim Types:
see list of patent claims
Device; Use;

Drugs Protected by US Patent 5,188,835

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 5,188,835

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Sweden8602666-3Jun 16, 1986

International Patents Family Members for US Patent 5,188,835

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 68097 ➤ Subscribe
Australia 599988 ➤ Subscribe
Australia 7422287 ➤ Subscribe
Canada 1314482 ➤ Subscribe
China 1034391 ➤ Subscribe
China 87104229 ➤ Subscribe
Germany 3773557 ➤ Subscribe
Denmark 175529 ➤ Subscribe
Denmark 303487 ➤ Subscribe
European Patent Office 0253109 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Chubb
Teva
Moodys
Federal Trade Commission
Cantor Fitzgerald
Fish and Richardson
Boehringer Ingelheim
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot